Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
- Status
- RECRUITING
- Phase
- PHASE3
Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants
- Status
- TERMINATED
- Phase
- PHASE2
Immunomodulation With Eltrombopag in ITP
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
- Status
- TERMINATED
- Phase
- PHASE1
Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
- Status
- COMPLETED
- Phase
- PHASE3
A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.
- Status
- TERMINATED
- Phase
- PHASE2
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)
- Status
- COMPLETED
- Phase
- PHASE4
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
- Status
- COMPLETED
- Phase
- PHASE3
Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia
- Status
- TERMINATED
- Phase
- PHASE1
Special Drug Use Surveillance for Entresto Tablets
- Status
- COMPLETED
- Phase
- N/A
Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.
- Status
- COMPLETED
- Phase
- PHASE4
Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C
- Status
- COMPLETED
- Phase
- PHASE1